肥厚型心肌病患者剧烈运动与室性心律失常风险
该前瞻性多中心队列研究纳入1660例8-60岁肥厚型心肌病或基因阳性/表型阴性个体,按自报运动强度分组,主要复合终点为死亡、复苏性心脏骤停、心律失常性晕厥和ICD适当放电。剧烈运动组与非剧烈运动组事件率分别为15.9和15.3/1000人年,校正HR 1.01,单侧95%置信上限1.48低于预设非劣效界值1.5,提示在经验中心治疗的此类患者中剧烈运动未增加死亡或危及生命心律失常风险。
要点
- 剧烈运动组与非剧烈运动组主要复合终点事件率相似(15.9 vs 15.3/1000人年)。
- 校正HR 1.01,单侧95%置信上限1.48低于非劣效界值1.5。
- 结果支持在经验中心与专家讨论后考虑剧烈运动参与。
核心结论
- 在经验中心治疗的肥厚型心肌病或基因阳性/表型阴性个体中,剧烈运动未增加死亡或危及生命心律失常风险。
研究设计与样本
- 研究者发起的多中心前瞻性观察性注册研究,2015年5月18日至2019年4月25日入组,2022年2月28日完成。
- 共纳入1660例8-60岁肥厚型心肌病或基因阳性/表型阴性个体,来自美国及国际42个高容量肥厚型心肌病中心,也可通过中心站点自我入组。
- 按自报体力活动水平分为久坐、中等或剧烈强度运动组。
主要发现
- 1660例参与者平均(SD)年龄39(15)岁,男性996例(60%)。
- 252例(15%)为久坐,709例(43%)为中等运动,699例(42%)为剧烈运动,其中259例(37%)参加竞技性运动。
- 77例(4.6%)达到主要复合终点,非剧烈运动组44例(4.6%),剧烈运动组33例(4.7%),对应发生率分别为15.3和15.9/1000人年。
- 多变量Cox回归分析主要复合终点,剧烈运动组校正HR 1.01,单侧95%置信上限1.48,低于预设非劣效界值1.5。
临床怎么用
- 对于在经验中心治疗的肥厚型心肌病或基因阳性/表型阴性个体,剧烈运动未显示增加死亡或危及生命心律失常风险,可作为医患讨论运动参与的参考。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Whether vigorous intensity exercise is associated with an increase in risk of ventricular arrhythmias in individuals with hypertrophic cardiomyopathy (HCM) is unknown. OBJECTIVE: To determine whether engagement in vigorous exercise is associated with increased risk for ventricular arrhythmias and/or mortality in individuals with HCM. The a priori hypothesis was that participants engaging in vigorous activity were not more likely to have an arrhythmic event or die than those who reported nonvigorous activity. DESIGN, SETTING, AND PARTICIPANTS: This was an investigator-initiated, prospective cohort study. Participants were enrolled from May 18, 2015, to April 25, 2019, with completion in February 28, 2022. Participants were categorized according to self-reported levels of physical activity: sedentary, moderate, or vigorous-intensity exercise. This was a multicenter, observational registry with recruitment at 42 high-volume HCM centers in the US and internationally; patients could also self-enroll through the central site. Individuals aged 8 to 60 years diagnosed with HCM or genotype positive without left ventricular hypertrophy (phenotype negative) without conditions precluding exercise were enrolled. EXPOSURES: Amount and intensity of physical activity. MAIN OUTCOMES AND MEASURES: The primary prespecified composite end point included death, resuscitated sudden cardiac arrest, arrhythmic syncope, and appropriate shock from an implantable cardioverter defibrillator. All outcome events were adjudicated by an events committee blinded to the patient's exercise category. RESULTS: Among the 1660 total participants (mean [SD] age, 39 [15] years; 996 male [60%]), 252 (15%) were classified as sedentary, and 709 (43%) participated in moderate exercise. Among the 699 individuals (42%) who participated in vigorous-intensity exercise, 259 (37%) participated competitively. A total of 77 individuals (4.6%) reached the composite end point. These individuals included 44 (4.6%) of those classified as nonvigorous and 33 (4.7%) of those classified as vigorous, with corresponding rates of 15.3 and 15.9 per 1000 person-years, respectively. In multivariate Cox regression analysis of the primary composite end point, individuals engaging in vigorous exercise did not experience a higher rate of events compared with the nonvigorous group with an adjusted hazard ratio of 1.01. The upper 95% 1-sided confidence level was 1.48, which was below the prespecified boundary of 1.5 for noninferiority. CONCLUSIONS AND RELEVANCE: Results of this cohort study suggest that among individuals with HCM or those who are genotype positive/phenotype negative and are treated in experienced centers, those exercising vigorously did not experience a higher rate of death or life-threatening arrhythmias than those exercising moderately or those who were sedentary. These data may inform discussion between the patient and their expert clinician around exercise participation.
引用
- Lampert R, Ackerman MJ, Marino BS, et al. Vigorous Exercise in Patients With Hypertrophic Cardiomyopathy. JAMA Cardiol. 2023. PMID: 37195701. doi:10.1001/jamacardio.2023.1042
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。